Drug screening using reprogramming resistance to overcome resistance to ALK-targeted therapy

被引：0
|
作者：
Utsumi, Takahiro [1 ]
Uchibori, Ken [2 ]
Nishio, Makoto [2 ]
Yamada, Yasuhiro [3 ]
Okamoto, Isamu [4 ]
Katayama, Ryohei [1 ]
机构：
[1] JFCR, Canc Chemother Ctr, Div Exp Chemother, Tokyo, Japan
[2] JFCR, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Resp Med, Fukuoka, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-1010
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] Mitochondria-targeted delivery of cisplatin could overcome drug resistance
    Potticary, James
    THERAPEUTIC DELIVERY, 2014, 5 (01) : 13 - 13
  • [22] Targeted therapy and drug resistance in thyroid cancer
    Zhang, Yujie
    Xing, Zhichao
    Liu, Tianyou
    Tang, Minghai
    Mi, Li
    Zhu, Jingqiang
    Wu, Wenshuang
    Wei, Tao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 238
  • [23] Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer
    Zhang, Rui
    Su, Chang
    Jia, Yongliang
    Xing, Menglu
    Jin, Shuiling
    Zong, Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [24] Shikonin a potent phytotherapeutic: a comprehensive review on metabolic reprogramming to overcome drug resistance in cancer
    Biswal, Stuti
    Sahoo, Sanjeeb Kumar
    Biswal, Bijesh K.
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [25] Codon-specific translation reprogramming promotes resistance to targeted therapy
    Francesca Rapino
    Sylvain Delaunay
    Florian Rambow
    Zhaoli Zhou
    Lars Tharun
    Pascal De Tullio
    Olga Sin
    Kateryna Shostak
    Sebastian Schmitz
    Jolanda Piepers
    Bart Ghesquière
    Latifa Karim
    Benoit Charloteaux
    Diane Jamart
    Alexandra Florin
    Charles Lambert
    Andrée Rorive
    Guy Jerusalem
    Eleonora Leucci
    Michael Dewaele
    Marc Vooijs
    Sebastian A. Leidel
    Michel Georges
    Marianne Voz
    Bernard Peers
    Reinhard Büttner
    Jean-Christophe Marine
    Alain Chariot
    Pierre Close
    Nature, 2018, 558 : 605 - 609
  • [26] New Strategies to Overcome Resistance in ALK Rearranged NSCLC
    Ou, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S58 - S59
  • [27] Codon-specific translation reprogramming promotes resistance to targeted therapy
    Rapino, Francesca
    Delaunay, Sylvain
    Rambow, Florian
    Zhou, Zhaoli
    Tharun, Lars
    De Tullio, Pascal
    Sin, Olga
    Shostak, Kateryna
    Schmitz, Sebastian
    Piepers, Jolanda
    Ghesquiere, Bart
    Karim, Latifa
    Charloteaux, Benoit
    Jamart, Diane
    Florin, Alexandra
    Lambert, Charles
    Rorive, Andree
    Jerusalem, Guy
    Leucci, Eleonora
    Dewaele, Michael
    Vooijs, Marc
    Leidel, Sebastian A.
    Georges, Michel
    Voz, Marianne
    Peers, Bernard
    Buettner, Reinhard
    Marine, Jean-Christophe
    Chariot, Alain
    Close, Pierre
    NATURE, 2018, 558 (7711) : 605 - +
  • [28] Escaping ALK Inhibition: Mechanisms of and Strategies to Overcome Resistance
    Lovly, Christine M.
    Pao, William
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (120)
  • [29] Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy
    Kim, B.
    Wang, S.
    Lee, J. M.
    Jeong, Y.
    Ahn, T.
    Son, D-S
    Park, H. W.
    Yoo, H-s
    Song, Y-J
    Lee, E.
    Oh, Y. M.
    Lee, S. B.
    Choi, J.
    Murray, J. C.
    Zhou, Y.
    Song, P. H.
    Kim, K-A
    Weiner, L. M.
    ONCOGENE, 2015, 34 (09) : 1083 - 1093
  • [30] Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy
    B Kim
    S Wang
    J M Lee
    Y Jeong
    T Ahn
    D-S Son
    H W Park
    H-s Yoo
    Y-J Song
    E Lee
    Y M Oh
    S B Lee
    J Choi
    J C Murray
    Y Zhou
    P H Song
    K-A Kim
    L M Weiner
    Oncogene, 2015, 34 : 1083 - 1093
12345